MK-2118
MK-2118 is a GMP-synthesized STING agonist with the potential to inhibit advanced/metastatic solid tumors or lymphomas..
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2218504-06-2
- Formule: C15H16O5S
- Masse moléculaire:308.35
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Essai clinique
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 2218504-06-2
-
Masse moléculaire 308.35
-
Formule C15H16O5S
-
SMILES
COC1=CC(SC(C(C[C@@H](C(O)=O)C)=O)=C2)=C2C=C1OC
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Hot Topics
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Regulation of Type I Interferon in the Prevention and Treatment of Viral and Inflammatory Diseases
Regulation of type I interferon in the prevention and treatment of viral and inflammatory diseases refers to the control of interferon-α and interferon-β production, signaling, and biological activity to balance antiviral defense with immune homeostasis.
2026-06-18
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)